1 / 15

Thrombocytopenia

Thrombocytopenia. Checkpoint Primary Hemostasis. It’s about vasculature It’s about platelets It’s about maintaining blood in a fluid state within the blood vessels and preventing excessive blood loss after vascular injury Bottomline Platelet Abnormalities –

adrina
Télécharger la présentation

Thrombocytopenia

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Thrombocytopenia

  2. Checkpoint Primary Hemostasis • It’s about vasculature • It’s about platelets • It’s about maintaining blood in a fluid state within the blood vessels and preventing excessive blood loss after vascular injury Bottomline Platelet Abnormalities – QUANTITAIVE OR QUALITATIVE result in bleeding Graphic accessed URL http://www.uv.es/~vicalegr/CLindex/CLvasculitis/vasleu11.jpg , 2005.

  3. Primary Skin petechiae purpura ecchymoses Mucous membranes nose bleeds sclera gums Secondary Tissues Joints Clinical ManifestationsPrimary v.s. Secondary Disorders of Hemostasis http://heme-coag.uthscsa.edu/wwwbleed97/22apet.gif

  4. Platelet-Associated Disorders • Quantitative – Numbers game • Increased = thrombocytosis • >450,000/ml • Decreased = thrombocytopenia • <150,000/ml http://www.mcl.tulane.edu/classware/pathology/Krause/ET/RM1.html http://lifesci.rutgers.edu/~babiarz/Histo/Blood/Smear2.jpg http://www.ispub.com/xml/journals/ijid/vol3n2/vivax-fig1.jpg

  5. Thrombocytopenia Definition • Thrombocytopenia is defined as a platelet count less than 150,000 • 2.5 percent of the normal population will have a platelet count lower than this

  6. Bleeding • Surgical bleeding: less than 50,000 • Spontaneous bleeding: less than 10,000 to 20,000 • Severe life threatening bleeding: less than 6000

  7. Thrombocytopenia

  8. Differential • Pseudothrombocytopenia • Decreased Production- suggested by: • other cytopenias • normal sized/small platelets suggest a reduced bone marrow response to need • Increased Destruction- suggested by: • Microangiopathic blood picture (fragmented RBCs, high LDH) • Large platelets on smear • Associated autoimmune disease

  9. Pseudothrombocytopenia • If blood sample is inadequately anticoagulated, platelet clumps can be counted as WBC’s • 0.1% of patients have EDTA dependent agglutinins leading to platelet clumping and pseudothrombocytopenia • Can also be seen after administration of abciximab • If platelet clumping is observed, repeat the count using heparin or citrate as anticoagulant

  10. Decreased platelet production • In almost all disorders caused by marrow suppression or damage, white cell and red cell production are also affected. • Viral infections- rubella, mumps, varicella, parvovirus, hepatitis C, EBV • Direct megakaryocyte damage-HIV • Post chemotherapy or radiation therapy • Acquired bone marrow hypoplasia- Fanconi anemia, acquired pure megakaryocytic aplasia • Direct alcohol toxicity • B12 or folate deficiency

  11. Increased Platelet destruction • ITP and SLE- mechanism presumed to be presence of autoimmune anti-platelet Abs • Alloimmune destruction- posttransfusion, post- transplantation • Hypersplenism • Disseminated intravascular coagulation • TTP- HUS • HELLP in pregnant women • Medications- heparin, quinine, valproic acid • Infections- EBV, CMV, sepsis • Physical destruction during cardiopulmonary bypass, intravascular or intracardiac metastatic lesions

  12. Pathophysiology of ITP O Autoantibody Production AP Platelet Opsonization O Platelet Destruction D AP D Platelet Production P T-Cell–Mediated Cytotoxicity TC P TC

  13. Diagnosis • Repeat lab • Peripheral smear • Coagulation study • Fibrinogen, d-dimer • ITP- presumptive diagnosis if history, physical examination, complete blood count, and examination of the peripheral blood smear do not suggest other etiologies. • Bone marrow biopsy- unexplained thrombocytopenia severe enough to constitute a risk for major bleeding

  14. History • Recent viral or rickettsial infection • Previously diagnosed hematologic disease • Nonhematologic diseases known to decrease platelet counts (eg, eclampsia, sepsis, DIC, anaphylactic shock, hypothermia, massive transfusions) • A positive family history of bleeding and/or thrombocytopenia • Recent live virus vaccination • Poor nutritional status, especially in the elderly and alcoholics • Medications • Pregnancy, especially late in the third trimester or at onset of labor • Recent organ transplantation from a donor sensitized to platelet alloantigens • Recent transfusion of a platelet-containing product in an allosensitized recipient

  15. Physical exam • Petechiae — pinhead sized, red, flat, discrete lesions often occurring in crops in dependent areas • Purpura — purplish discoloration of the skin due to the presence of confluent petechiae. • Ecchymoses — nontender areas of bleeding into the skin, usually associated with multiple colors, due to the presence of extravasated blood

More Related